Stuart Lutzker's most recent trade in ArriVent BioPharma Inc. was a trade of 120,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ArriVent BioPharma Inc. | Stuart Lutzker | Director, President of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 120,000 | 120,000 | - | - | Stock Option (right to buy) |